广州伟伯科技有限公司
您的位置:首页 > 产品中心 > Lipopolysaccharides from Akkermansia muciniphila
产品搜索:

Lipopolysaccharides from Akkermansia muciniphila

产品编号:4085411
规格:Purified by phenol extraction
包装规格:5 MG
产品类别:进口试剂
品牌:Sigma-Aldrich
优惠价:立即咨询
产品价格
产品编号包装单位单价(元)国内现货国外库存询价单
40854115 MG2820
产品性质
Quality Level【质量水平】
100
form【形式】
lyophilized powder
storage temp.【储存温度】
2-8℃
基本信息
Biochem/physiol Actions【生化/生理作用】
Lipopolysaccharides (LPSs) are characteristic components of the cell wall of gram-negative bacteria. LPS and its lipid A moiety stimulate cells of the innate immune system by the Toll-like receptor 4 (TLR4), a member of the Toll-like receptor protein family, which recognizes common pathogen-associated molecular-patterns (PAMPs).,
Akkermansia muciniphila (A. muciniphila) is a gram negative, anaerobic, non motile, non spore forming and oval shaped bacterium. A. muciniphila inhabits the gastrointestinal tracts of more than 90% of adults and constitutes 1-4% of the fecal microbiota. A. muciniphila levels were suggested to serve as biomarker for a healthy intestine.
A. muciniphila degrades mucus and utilizes it as a carbon/nitrogen source. Consequently, the host produces additional mucus while the bacterium produces oligosaccharides and Short Chain Fatty Acids (SCFAs) that can be utilized by the host and trigger the immune system. An additional protective effect of the SCFA is stimulation of mucus-associated microbiota growth, that serves as a barrier against penetration of pathogens to intestinal cells.,
A. muciniphila was crowned as the next-generation beneficial microbe. Several reports have indicated that A. muciniphila affects glucose metabolism, lipid metabolism, and intestinal immunity. In addition, decreasing levels of A. muciniphila are related to the development of some diseases such as metabolic disorders and inflammatory diseases (obesity, type 2 diabetes, inflammatory bowel disease (IBD), autism and atopy. Weir et al. found a correlation between low level of A. muciniphila and colorectal cancer. Shigemetzu Y et al. found that A. muciniphila acts as a regulator of the response to PD-1 blockade which is used for anti-cancer immunotherapy. A. muciniphila induce dendritic cells to secrete IL-12, that is a critical component of the anti-cancer effect of PD-1 blockade.
LPSs from A. muciniphila stimulate NF-κB dependent secreted embryonic cell alkaline phosphatase (SEAP) production via TLR4. In addition, it induces IL-8, IL-6 and minimal amounts of IL-10 and TNF-α in peripheral blood mononuclear cells (PBMCs). A. muciniphila stimulation of IL-8 production by enterocytes was shown to be significantly (100 fold) lower than E. coli stimulation. Low proinflammatory activity keep the mucosa-associated immune system alerted at an appropriate level for generation of mucosal homeostasis.
安全信息
Pictograms【象形图】
GHS06
Signal word【警示用语:】
Danger
Hazard Statements
H300
Precautionary Statements
P301 + P310 + P330
Hazard Classifications【危险分类】
Acute Tox. 2 Oral
Storage Class Code【储存分类代码】
6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials
WGK
WGK 3
广州伟伯科技有限公司 版权所有 CopyRight ©2006-2024, All Rights Reserved
工信部备案号:粤ICP备08114744号   Page Run Time: 0.0086